Fresenius Medical Care (FMEA) Stock Statistics & Valuation Metrics
Total Valuation
Fresenius Medical Care has a market cap or net worth of EUR 10.73B. The enterprise value is EUR 24.57B.
- Market Cap
- EUR 10.73B
- Enterprise Value
- EUR 24.57B
Share Statistics
Fresenius Medical Care has 537,129,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 537,129,300
- Owned by Insiders
- ―
- Owned by Institutions
- 6.86%
Financial Efficiency
Fresenius Medical Care’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.34%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 5.34%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 181.46K
- Profits Per Employee
- 9,045.135
- Employee Count
- 108,165
- Asset Turnover
- 0.63
- Inventory Turnover
- 6.82
Valuation Ratios
The current PE Ratio of Fresenius Medical Care is 11.76. Fresenius Medical Care’s PEG ratio is 0.25.
- PE Ratio
- 11.76
- PS Ratio
- 0.53
- PB Ratio
- 0.83
- Price to FCF
- 5.82
- Price to Operating Cash Flow
- 3.70
- PEG Ratio
- 0.25
Income Statement
In the last 12 months, Fresenius Medical Care had revenue of 19.63B and earned 978.37M in profits. Earnings per share was 1.68.
- Revenue
- 19.63B
- Gross Profit
- 5.03B
- Operating Income
- 1.83B
- Pretax Income
- 1.51B
- Net Income
- 978.37M
- EBITDA
- 3.40B
- Earnings Per Share (EPS)
- 1.68
Cash Flow
In the last 12 months, operating cash flow was 2.80B and capital expenditures -1.03B, giving a free cash flow of 1.77B billion.
- Operating Cash Flow
- 2.80B
- Free Cash Flow
- 1.77B
- Free Cash Flow per Share
- 3.32
Dividends & Yields
Fresenius Medical Care pays an annual dividend of ―, resulting in a dividend yield of 3.66%
- Dividend Per Share
- ―
- Dividend Yield
- 3.66%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 17.18%
- Earnings Yield
- 8.95%
Stock Price Statistics
- Beta
- 0.43
- 52-Week Price Change
- -11.40%
- 50-Day Moving Average
- 19.44
- 200-Day Moving Average
- 19.34
- Relative Strength Index (RSI)
- 59.52
- Average Volume (3m)
- 306
Important Dates
Fresenius Medical Care upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- ―
Financial Position
Fresenius Medical Care as a current ratio of 1.26, with Debt / Equity ratio of 75.58%
- Current Ratio
- 1.26
- Quick Ratio
- 0.92
- Debt to Market Cap
- 0.62
- Net Debt to EBITDA
- 2.71
- Interest Coverage Ratio
- 4.75
Taxes
In the past 12 months, Fresenius Medical Care has paid 320.97M in taxes.
- Income Tax
- 320.97M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Fresenius Medical Care EV to EBITDA ratio is 5.72, with an EV/FCF ratio of 11.37.
- EV to Sales
- 1.04
- EV to EBITDA
- 5.72
- EV to Free Cash Flow
- 11.37
- EV to Operating Cash Flow
- 7.17
Balance Sheet
Fresenius Medical Care has EUR 1.45B in cash and marketable securities with EUR 10.96B in debt, giving a net cash position of -EUR 9.51B billion.
- Cash & Marketable Securities
- EUR 1.45B
- Total Debt
- EUR 10.96B
- Net Cash
- -EUR 9.51B
- Net Cash Per Share
- -EUR 17.71
- Tangible Book Value Per Share
- -EUR 3.18
Margins
Gross margin is 26.36%, with operating margin of 10.69%, and net profit margin of 4.83%.
- Gross Margin
- 26.36%
- Operating Margin
- 10.69%
- Pretax Margin
- 7.73%
- Net Profit Margin
- 4.83%
- EBITDA Margin
- 18.27%
- EBIT Margin
- 10.82%
Analyst Forecast
The average price target for Fresenius Medical Care is EUR 22.26, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 22.26
- Price Target Upside
- 10.21% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 2
- Revenue Growth Forecast
- -0.47%
- EPS Growth Forecast
- 48.60%
Scores
- Smart Score
- 4
- AI Score
- ―
